Stefan Wiehr

Stefan Wiehr

Auto-generated profile, based on publicly available information

Stefan Wiehr

Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, GERMANY

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2014 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
CGChristoph M. Griessinger
Christoph M. Griessinger
RKRainer Kehlbach
Rainer Kehlbach
DBDaniel Bukala
Daniel Bukala
SWStefan Wiehr
Stefan Wiehr
RBRüdiger Bantleon
Rüdiger Bantleon
MKManfred Kneilling
Manfred Kneilling
Although T cells can be labeled for noninvasive in vivo imaging, little is known about the impact of such labeling on T-cell function, and most imaging methods do not provide holistic information about trafficking kinetics, homing sites, or quantification. Methods: We developed protocols that minimize the inhibitory effects of 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (64Cu-PTSM) labeling on T-cell function and permit the homing patterns of T cells to be followed by PET. Thus, we labeled ovalbumin (OVA) T-cell receptor transgenic interferon (IFN)-γ–producing CD4+ T (Th1) cells with 0.7–2.2 MBq of 64Cu-PTSM and analyzed cell viability, IFN-γ production, proliferation, apoptosis, and DNA double-strand breaks and identified intracellular 64Cu accumulation sites by energy dispersive x-ray analysis. To elucidate the fate of Th1 cell homing by PET, 107 64Cu-OVA-Th1 cells were injected intraperitoneally or intravenously into healthy mice. To test the functional capacities of 64Cu-OVA-Th1 cells during experimental OVA-induced airway hyperreactivity, we injected 107 64Cu-OVA-Th1 cells intraperitoneally into OVA-immunized or nonimmunized healthy mice, which were challenged with OVA peptide or phosphate-buffered saline or remained untreated. In vivo PET investigations were followed by biodistribution, autoradiography, and fluorescence-activated cell sorting analysis. Results: PET revealed unexpected homing patterns depending on the mode of T-cell administration. Within 20 min after intraperitoneal administration, 64Cu-OVA-Th1 cells homed to the perithymic lymph nodes (LNs) of naive mice. Interestingly, intravenously administered 64Cu-OVA-Th1 cells homed predominantly into the lung and spleen but not into the perithymic LNs. The accumulation of 64Cu-OVA-Th1 cells in the pulmonary LNs (6.8 ± 1.1 percentage injected dose per cubic centimeter [%ID/cm3]) 24 h after injection was highest in the OVA-immunized and OVA-challenged OVA airway hyperreactivity–diseased littermates 24 h after intraperitoneal administration and lowest in the untreated littermates (3.7 ± 0.4 %ID/cm3). As expected, 64Cu-OVA-Th1 cells also accumulated significantly in the pulmonary LNs of nonimmunized OVA-challenged animals (6.1 ± 0.5 %ID/cm3) when compared with phosphate-buffered saline–challenged animals (4.6 ± 0.5 %ID/cm3). Conclusion: Our protocol permits the detection of Th1 cells in single LNs and enables temporal in vivo monitoring of T-cell homing over 48 h. This work enables future applications for 64Cu-PTSM–labeled T cells in clinical trials and novel therapy concepts focusing on T-cell–based immunotherapies of autoimmune diseases or cancer.

6 January 2015 in Molecular Imaging and Biology
Verified
Journal Article
Closed access
PDF file
ARAnna-Maria Rolle
Anna-Maria Rolle
PSPeter Soboslay
Peter Soboslay
Gerald ReischlGerald Reischl
Gerald Reischl
WHWolfgang H. Hoffmann
Wolfgang H. Hoffmann
BPBernd J. Pichler
Bernd J. Pichler
SWStefan Wiehr
Stefan Wiehr

4 October 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SWStefan Wiehr
Stefan Wiehr
ARAnna-Maria Rolle
Anna-Maria Rolle
PWPhilipp Warnke
Philipp Warnke
UKUrsula Kohlhofer
Ursula Kohlhofer
LQLeticia Quintanilla-Martinez
Leticia Quintanilla-Martinez
SAStella Eugenie Autenrieth
Stella Eugenie Autenrieth
Most frequently, gram-negative bacterial infections in humans are caused by Enterobacteriaceae and remain a major challenge in medical diagnostics. We non-invasively imaged moderate and severe systemic Yersinia enterocolitica infections in mice using the positron emission tomography (PET) tracer 3’-deoxy-3’-[18F]fluorothymidine ([18F]FLT), which is a marker of proliferation, and compared the in vivo results to the ex vivo biodistributions, bacterial loads, and histologies of the corresponding organs. Y. enterocolitica infection is detectable with histology using H&E staining and immunohistochemistry for Ki 67. [18F]FLT revealed only background uptake in the spleen, which is the main manifestation site of systemic Y. enterocolitica-infected mice. The uptake was independent of the infection dose. Antibody-based thymidine kinase 1 (Tk-1) staining confirmed the negative [18F]FLT-PET data. Histological alterations of spleen tissue, observed via Ki 67-antibody-based staining, can not be detected by [18F]FLT-PET in this model. Thus, the proliferation marker [18F]FLT is not a suitable tracer for the diagnosis of systemic Y. enterocolitica infection in the C57BL/6 animal model of yersiniosis.